| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL BISULFATE | 94 |
| 1 | CLOPIDOGREL | 93 |
| 2 | OMEPRAZOLE MAGNESIUM | 46 |
| 3 | OMEPRAZOLE | 40 |
| 4 | INSULIN GLARGINE | 33 |
| 5 | METFORMIN | 29 |
| 6 | INSULIN ASPART | 26 |
| 7 | PANTOPRAZOLE | 24 |
| 8 | INSULIN GLARGINE-YFGN | 22 |
| 9 | OXALIPLATIN | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIAZOXIDE | 3 | 0.0041 |
| 1 | FERRIC CARBOXYMALTOSE | 11 | 0.0023 |
| 2 | METHYLDOPA | 11 | 0.0022 |
| 3 | CAPTOPRIL | 15 | 0.0016 |
| 4 | ACARBOSE | 6 | 0.0015 |
| 5 | METHIMAZOLE | 12 | 0.0015 |
| 6 | LEVOLEUCOVORIN INJECTION | 4 | 0.0013 |
| 7 | GLUTATHIONE | 2 | 0.0012 |
| 8 | LEVOLEUCOVORIN | 4 | 0.0010 |
| 9 | INSULIN GLARGINE-YFGN | 22 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | P2Y12 Platelet Inhibitor [EPC] | 82 |
| 1 | Proton Pump Inhibitor [EPC] | 55 |
| 2 | Insulin Analog [EPC] | 54 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 29 |
| 4 | Corticosteroid [EPC] | 27 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 6 | Loop Diuretic [EPC] | 23 |
| 7 | Platinum-based Drug [EPC] | 21 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 12 | 0.0012 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 6 | 0.0012 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 82 | 0.0007 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 4 | Bile Acid [EPC] | 10 | 0.0004 |
| 5 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 13 | 0.0004 |
| 6 | Alkaloid [EPC] | 10 | 0.0004 |
| 7 | Antimycobacterial [EPC] | 7 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |